TOP TIERMARKET NEWSWIRE
SEC Form 4 history

ACRIVON THERAPEUTICS (ACRV) insider trades

ACRIVON THERAPEUTICS (ACRV) insider trading activity (SEC Form 4). Over the trailing 90 days, ACRV insiders filed 0 purchases totalling $0 and 8 sales totalling $40K — net SELLING of $40K. Most recent filing: Aug 27, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
8
$40K
Net (90d)
-$40K
net selling
Most recent
Aug 27, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Aug 27, 2026Blume-Jensen PeterPres, CEOS Sale—$2.21$31Kfiling
Aug 20, 2026Peterson KatharineChief Accounting OfficerS Sale—$2.01$203filing
Aug 20, 2026Devroe EricCOOS Sale—$2.01$1Kfiling
Aug 20, 2026Gamelin ErickChief Development OfficerS Sale—$2.01$804filing
Aug 20, 2026Miller MaryGCS Sale—$2.01$372filing
Aug 20, 2026Blume-Jensen PeterPres, CEOS Sale—$2.01$3Kfiling
Aug 6, 2026Levy Adam D.CFOS Sale—$1.57$2Kfiling
Jul 23, 2026Miller MaryGCS Sale—$1.76$1Kfiling